What to Know About New Covid Vaccines for Fall 2026

As we edge closer to fall 2026, new Covid vaccines have been approved for distribution, targeting individuals aged 65 and older and younger people with specific underlying health conditions. Although others might access these vaccines off-label, the primary focus remains on those at higher risk. This development underscores ongoing efforts to bolster public health defenses against the virus, reflecting a significant step forward in vaccine availability and tailored healthcare strategies. For more details, check out the full article from The New York Times.